Document is current
Any future updates will be listed below
-
Authors
Ziai, Wendy C. https://orcid.org/0000-0003-4548-7353
Yarava, Anusha
Gruber, Joshua B.
Li, Yunke
Walborn, Nathan
Rizzutti, Nick
Hildreth, Meghan
Awad, Issam
Hanley, Daniel F.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01NS080824)
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 19 August 2025
First Online: 16 September 2025
Declarations
:
: A.Y., N.W., N.R., I.A., D.F.H., and W.C.Z. report grant support from the National Institute of Neurological Disorders and Stroke, during the conduct of the study. I.A. reports consulting fees from Neurelis and Graviton unrelated to the submitted work and medicolegal consulting. D.F.H. reports personal fees from Neurotrope, Neurelis, and medicolegal outside of the submitted work. W.C.Z. is an associate editor for the journal Neurocritical Care . All other authors declare no competing interests.
: This study was approved by the Johns Hopkins Institutional Review Board. Written informed consent was obtained from all participants or their legally authorized representatives as part of the MISTIE III clinical trial.
